1242257-11-9

Basic information

• Product Name: 2-(4-bromophenyl)-5-chloro-Oxazolo[5,4-d]pyrimidine
• Synonyms: 2-(4-bromophenyl)-5-chloro-Oxazolo[5,4-d]pyrimidine
• CAS NO: 1242257-11-9
• Molecular Weight: 310.537
• Mol File: 1242257-11-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(4-bromophenyl)-5-chloro-Oxazolo[5,4-d]pyrimidine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-bromophenyl)-5-chloro-Oxazolo[5,4-d]pyrimidine(1242257-11-9)
• EPA Substance Registry System: 2-(4-bromophenyl)-5-chloro-Oxazolo[5,4-d]pyrimidine(1242257-11-9)

Safety Data

• Hazardous Substances Data: 1242257-11-9(Hazardous Substances Data)

Usage

Chemical class

Oxazolo[5,4-d]pyrimidine
A heterocyclic compound containing both oxygen and nitrogen atoms in its ring structure.

Molecular structure

4-bromophenyl group and 5-chloro atom
Characterized by the presence of these two functional groups.

Heterocyclic compound

Containing oxygen and nitrogen atoms
The compound has a ring structure with both types of atoms.

Potential applications

Pharmaceutical industry
It can be used in the development of new drugs targeting specific biological processes.

Biological activities

Diverse potential activities
The compound may exhibit various biological effects, which need further research.

Synthesis building block

Organic compound synthesis
It can be used as a starting material or intermediate in the synthesis of other organic compounds.

Further research

Necessary for understanding potential uses and properties
More studies are needed to fully explore the capabilities and characteristics of 2-(4-bromophenyl)-5-chloro-Oxazolo[5,4-d]pyrimidine.

Downstream Products

• 1315312-41-4 2-(4-bromo-phenyl)-5-(2-fluoro-phenoxy)-oxazolo[5,4-d]pyrimidine 
• 1315472-51-5 (S)-1-((E)-3-{4-[5-(2-fluoro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-phenyl}-acryloyl)-pyrrolidine-2-carboxylic acid tert-butyl ester 
• 1315472-15-1 (S)-1-((E)-3-{4-[5-(2-fluoro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-phenyl}-acryloyl)-pyrrolidine-2-carboxylic acid 
• 1315472-16-2 (S)-1-(3-{4-[5-(2-fluoro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-phenyl}-propionyl)-pyrrolidine-2-carboxylic acid 
• 1315311-08-0 (E)-3-{4-[5-(2-fluoro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-phenyl}-acrylic acid 
• 1315312-42-5 (E)-3-{4-[5-(2-fluoro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-phenyl}-acrylic acid tert-butyl ester 

Relevant articles and documents

HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING

Heterocyclic carboxylic acid derivatives comprising a 2,5-substituted oxazolopyrimidine ring as Edg-1 receptor agonists The present invention relates to oxazolopyrimidine compounds of the formula I, in which A, R1, R2, R3, X and Y are defined as indicated in the claims. The compounds of the formula I modulate the activity of the Edg-1 receptor and in particular are agonists of this receptor, and are useful for the treatment of diseases such as atherosclerosis, heart failure or peripheral arterial occlusive disease, for example. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.